Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Initiative Program Official Sort descending
Cao, Yin

Washington University
United States

PROSPECT-Global Consortium and Risk Factor Discovery 3OT2CA297576-01S1 Asad Umar, D.V.M., Ph.D.
Spector, Tim

King'S College London
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 1OT2CA297289-01 Asad Umar, D.V.M., Ph.D.
Acciavatti, Raymond Joseph

University Of Pennsylvania
United States

Next-Generation Tomosynthesis Pilot Study 5R37CA273959-04 Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome 5R01CA260761-04 Asad Umar, D.V.M., Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297680-01S1 Asad Umar, D.V.M., Ph.D.
Curtius, Kathleen M.

University Of California, San Diego
United States

Multiscale modeling of spatiotemporal evolution in Barrett's esophagus 5R01CA270235-03 Asad Umar, D.V.M., Ph.D.
Markowitz, Sanford D.

Case Western Reserve University
United States

A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression 5R01CA295877-02 Asad Umar, D.V.M., Ph.D.
Mehrara, Babak J

Sloan-Kettering Inst Can Research
United States

Mechanisms of racial disparity in breast cancer-related lymphedema 5R01CA278599-04 Asad Umar, D.V.M., Ph.D.
Warner, Erica T

Massachusetts General Hospital
United States

Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon 3U01CA301988-02S1 Asad Umar, D.V.M., Ph.D.
Plas, Ellen Van Der

Arkansas Children'S Hospital Res Inst
United States

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia 5R37CA266135-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Asad Umar, D.V.M., Ph.D.